Nonpharmacologic and pharmacologic treatment of patients with low levels of high-density lipoprotein cholesterol.

Published

Journal Article (Review)

Low levels of high-density lipoprotein cholesterol (HDL-C) constitute a strong risk factor for developing coronary heart disease. This risk can be decreased by even slight improvements in HDL-C levels. This review discusses both pharmacologic and nonpharmacologic treatments of patients with low levels of HDL-C, including lifestyle modifications and the benefits of oral estrogens, niacin, fibrates, statins, and combination drug therapy.

Full Text

Duke Authors

Cited Authors

  • Bowen, PH; Guyton, JR

Published Date

  • January 2000

Published In

Volume / Issue

  • 2 / 1

Start / End Page

  • 58 - 63

PubMed ID

  • 11122725

Pubmed Central ID

  • 11122725

International Standard Serial Number (ISSN)

  • 1523-3804

Language

  • eng

Conference Location

  • United States